已收盘 12-24 16:00:00 美东时间
-0.072
-10.48%
ProPhase Labs and ABL have entered a non-binding Letter of Intent for a proposed reverse merger, aiming to deliver near-term value to ProPhase shareholders and long-term growth for ABL. Under the agreement, ABL would become the majority owner of the combined entity, owning approximately 76% of the shares. ProPhase shareholders may receive a special cash dividend of up to $10 million, with all Crown Medical Collections receivables also carved out ...
12-19 12:00
Gainers Lexaria Bioscience (NASDAQ:LEXX) stock increased by 6.5% to $0.89 durin...
12-17 05:05
On November 30, 2025, the Company's stockholders approved an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock at a ratio of one (1) shares for
12-13 00:48
Prophase Labs ( ($PRPH) ) has shared an announcement. On November 24, 2025, Pro...
11-27 03:47
ProPhase Labs invites investors to an exclusive webinar on December 1, 2025, at 4:15 p.m. ET, hosted by RedChip Companies. CEO Ted Karkus will discuss ProPhase’s high-growth healthcare assets, including the FDA-approved BE-Smart Esophageal Cancer Test, strategic initiatives with Crown Medical Collections, and its consumer genomics business Nebula Genomics. Multiple near-term catalysts, such as BE-Smart commercialization, position the company for ...
11-26 13:00
Prophase Labs ( ($PRPH) ) has shared an announcement. On November 21, 2025, Pro...
11-26 05:59
An update from Prophase Labs ( ($PRPH) ) is now available. On November 19, 2025...
11-19 22:30
ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 54.29 percent increase over losses of $(0.35) per share from
11-19 21:16
Companies Reporting Before The Bell • Lowe's Companies (NYSE:LOW) is expected t...
11-19 19:11
ProPhase Labs (NASDAQ:PRPH) is set to give its latest quarterly earnings report...
11-19 00:03